Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Because retatrutide is newer than semaglutide and tirzepatide, the available protocol literature is smaller though growing quickly as clinical trial data publishes
It is an extensively engineered, synthetically derived 39-amino-acid peptide specifically designed to function as a highly balanced triple agonist targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR)
Mild, localised injection site reactions that resolve within a week often do not require stopping treatment
US$ 23.52
US$ 21.68
US$ 21.60
US$ 24.81
US$ 21.76
US$ 21.99
